These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 88775)

  • 21. Absence of close linkage between acute intermittent porphyria and the ABO, Rh, P, acid phosphatase, Pr, orosmucoid and pepsinogen loci.
    Dean KS; Conneally PM; Sassa S; Anderson KE
    Hum Hered; 1982; 32(3):189-92. PubMed ID: 6955272
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acute intermittent porphyria at 4 months of age].
    Beauvais P; Klein ML; Denave L; Martel C
    Arch Fr Pediatr; 1976 Dec; 33(10):987-92. PubMed ID: 1015983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Red blood cell porphobilinogen deaminase in the evaluation of acute intermittent porphyria.
    Pierach CA; Weimer MK; Cardinal RA; Bossenmaier IC; Bloomer JR
    JAMA; 1987 Jan; 257(1):60-1. PubMed ID: 3783903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linkage relationships of the loci of the major histocompatibility complex in families with a recombination in the HLA region.
    Bijnen AB; Schreuder I; Meera Khan P; Allen FH; Giles CM; Los WR; Volkers WS; van Rood JJ
    J Immunogenet; 1976 Jun; 3(3):171-83. PubMed ID: 965767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-A3 and -B7 in porphyria cutanea tarda.
    Kuntz BM; Goerz G; Merk H; Strohmeyer G; Brüster HT
    Tissue Antigens; 1984 Jul; 24(1):67-9. PubMed ID: 6484933
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria.
    Kostrzewska E; Gregor A
    Ann Clin Res; 1986; 18(4):195-8. PubMed ID: 3789651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnosis of acute intermittent porphyria. Usefulness and limitations of the erythrocyte uroporphyrinogen I synthase assay.
    Bottomley SS; Bonkowsky HL; Kreimer-Birnbaum M
    Am J Clin Pathol; 1981 Aug; 76(2):133-9. PubMed ID: 7270494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythrocyte uroporphyrinogen I synthase activity in diagnosis of acute intermittent porphyria.
    Peterson LR; Hamernyik P; Bird TD; Labbé RF
    Clin Chem; 1976 Nov; 22(11):1835-40. PubMed ID: 975542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase.
    Elder GH; Sheppard DM; De Salamanca RE; Olmos A
    Clin Sci (Lond); 1980 Jun; 58(6):477-84. PubMed ID: 7428280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigations of red cell glyoxalase in recombinant families.
    Pretorius AM; Scholz S; Kuntz B; Albert ED
    Eur J Immunol; 1976 Oct; 6(10):759-61. PubMed ID: 1015713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Red cell uroporphyrinogen I synthetase in acute intermittent porphyria.
    Mustajoki P
    Ann Clin Res; 1976; 8 Suppl 17():133-8. PubMed ID: 1008483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel assocation between HLA and disease: porphyria cutanea tarda and HLA-AW32.
    Santoianni P; De Felice M; Ayala F; Budillon G; Zappacosta S
    Dermatologica; 1980; 160(6):371-5. PubMed ID: 7389968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of the diagnostic usefulness of determining porphobilinogen deaminase activity in the erythrocytes in patients with acute intermittent porphyria and in carriers of the gene of this type of porphyria].
    Gregor A; Kocyłowski M; Kostrzewska E
    Przegl Lek; 1986; 43(11):703-5. PubMed ID: 3575772
    [No Abstract]   [Full Text] [Related]  

  • 34. New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation.
    Doss M; von Tiepermann R; Schneider J; Schmid H
    Klin Wochenschr; 1979 Oct; 57(20):1123-7. PubMed ID: 513604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of the human GLO gene locus.
    Olaisen B; Gedde-Dahl T; Thorsby E
    Hum Genet; 1976 Jun; 32(3):301-4. PubMed ID: 939550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-linked hemochromatosis alleles in sporadic porphyria cutanea tarda.
    Edwards CQ; Griffen LM; Goldgar DE; Skolnick MH; Kushner JP
    Gastroenterology; 1989 Oct; 97(4):972-81. PubMed ID: 2789160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The HLA system and porphyria cutanea tarda].
    Köstler E; Gebhardt B; Seebacher C
    Dtsch Z Verdau Stoffwechselkr; 1984; 44(2):95-100. PubMed ID: 6592073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-linked hemochromatosis and sporadic porphyria cutanea tarda.
    Gastroenterology; 1986 Mar; 90(3):800-1. PubMed ID: 3943706
    [No Abstract]   [Full Text] [Related]  

  • 39. [HLA antigen distribution and porphyria cutanea tarda--a contribution on the problem of the association of HLA with metabolic diseases].
    Gebhardt B; Köstler E; Seebacher C
    Dermatol Monatsschr; 1984; 170(8):506-10. PubMed ID: 6479408
    [No Abstract]   [Full Text] [Related]  

  • 40. Denaturing gradient gel electrophoresis for rapid detection of latent carriers of a subtype of acute intermittent porphyria with normal erythrocyte porphobilinogen deaminase activity.
    Bourgeois F; Gu XF; Deybach JC; Te Velde MP; de Rooij F; Nordmann Y; Grandchamp B
    Clin Chem; 1992 Jan; 38(1):93-5. PubMed ID: 1733614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.